Vor Biopharma Inc., a biotechnology firm specializing in biological products, has announced a significant adjustment to the exercise prices of certain stock options. On Monday, the company's board of ...
At more than 22% out of the money. The increased activity in these call options suggests that speculators are bullish on Broadcom, rising to $300 and above over the intermediate-term future. Put that ...